NCT02898805View on ClinicalTrials.gov

Effects of LopiGLIK® on Cardiovascular Risk

NACompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

December 1, 2018

Conditions
Cardiovascular Risk Factors
Interventions
OTHER

Placebo

OTHER

Prescribed Diet

DIETARY_SUPPLEMENT

LopiGLIK®

DIETARY_SUPPLEMENT

Armolipid Plus

Trial Locations (1)

80131

Federico II University, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT02898805 - Effects of LopiGLIK® on Cardiovascular Risk | Biotech Hunter | Biotech Hunter